Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

NCT06837454 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06837454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06837454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
February 4, 2025
Completion date
May 13, 2027
Enrollment
600 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis